PASSAGE BIO, INC. Accumulated Other Comprehensive Income
PASSAGE BIO, INC. (PASG) had Accumulated Other Comprehensive Income of $8.00 thousand as of 2024-12-31, per its S-4/A filed 2026-09-03.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-09-03
- 2024-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $8.00K.
- 2024-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $32.00K.
- 2024-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$67.00K.
- 2024-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$69.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2024-12-31 | $8.00K S-4/A · filed 2026-09-03 |
| 2024-09-30 | $32.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | -$67.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$69.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | -$43.00K 10-K · filed 2025-03-04 |
| 2023-09-30 | -$192.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$340.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | -$427.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$966.00K 10-K · filed 2024-03-04 |
| 2022-09-30 | -$1.47M 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$1.58M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$1.33M 10-Q · filed 2022-05-16 |
| 2021-12-31 | -$413.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | $33.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $19.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$7.00K 10-Q · filed 2021-05-05 |
| 2020-12-31 | -$12.00K 10-K · filed 2022-03-03 |
| 2020-09-30 | -$40.00K 10-Q · filed 2020-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |